These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12085981)

  • 1. Angiotensin converting enzyme inhibition in heart failure: clinical trials and clinical practice.
    Squire lB
    Cardiovasc Drugs Ther; 2002 Jan; 16(1):67-74. PubMed ID: 12085981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: a multilevel study.
    Kasje WN; Denig P; Stewart RE; de Graeff PA; Haaijer-Ruskamp FM
    Eur J Clin Pharmacol; 2005 Apr; 61(2):145-51. PubMed ID: 15761751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure.
    Chin MH; Friedmann PD; Cassel CK; Lang RM
    J Gen Intern Med; 1997 Sep; 12(9):523-30. PubMed ID: 9294785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners?
    Houghton AR; Cowley AJ
    Int J Cardiol; 1997 Mar; 59(1):7-10. PubMed ID: 9080020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin converting enzyme (ACE) inhibitors in the treatment of heart failure in general practice in north Cumbria.
    Toal M; Walker R
    Eur J Heart Fail; 2000 Jun; 2(2):201-7. PubMed ID: 10856735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underutilisation of ACE inhibitors in patients with congestive heart failure.
    Bungard TJ; McAlister FA; Johnson JA; Tsuyuki RT
    Drugs; 2001; 61(14):2021-33. PubMed ID: 11735631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals.
    Philbin EF; Andreaou C; Rocco TA; Lynch LJ; Baker SL
    Am J Cardiol; 1996 Apr; 77(10):832-8. PubMed ID: 8623735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing and emergency admissions for heart failure in greater Glasgow.
    Davie AP; Morrison CE; Forrester JE; Mcmurray JJ
    J Card Fail; 1999 Mar; 5(1):3-7. PubMed ID: 10194654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blockers and angiotensin-converting enzyme inhibitors/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada.
    Johnson D; Jin Y; Quan H; Cujec B
    J Am Coll Cardiol; 2003 Oct; 42(8):1438-45. PubMed ID: 14563589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community pharmacist outreach program directed at physicians treating congestive heart failure.
    Turner CJ; Parfrey P; Ryan K; Miller R; Brown A
    Am J Health Syst Pharm; 2000 Apr; 57(8):747-52. PubMed ID: 10786260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibitor compliance and dosing among patients with heart failure.
    Roe CM; Motheral BR; Teitelbaum F; Rich MW
    Am Heart J; 1999 Nov; 138(5 Pt 1):818-25. PubMed ID: 10539811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of angiotensin-converting enzyme inhibitors in myocardial infarction and congestive heart failure: implications for clinical practice.
    Pitt B
    Cardiology; 1995; 86 Suppl 1():41-5. PubMed ID: 7614506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors determining angiotensin-converting enzyme inhibitor underutilization in heart failure in a community setting.
    Philbin EF
    Clin Cardiol; 1998 Feb; 21(2):103-8. PubMed ID: 9491949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving ACE inhibitor use in patients hospitalized with systolic heart failure: a cluster randomized controlled trial of clinical practice guideline development and use.
    Thilly N; Briançon S; Juillière Y; Dufay E; Zannad F
    J Eval Clin Pract; 2003 Aug; 9(3):373-82. PubMed ID: 12895159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin converting enzyme (ACE) inhibitors and heart failure. The consequences of underprescribing.
    Andersson F; Cline C; Rydén-Bergsten T; Erhardt L
    Pharmacoeconomics; 1999 Jun; 15(6):535-50. PubMed ID: 10538327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart failure and angiotensin-converting enzyme inhibitors. Is there a need for specialty care?
    Scheiner MA; Kimmel SE
    J Gen Intern Med; 1997 Sep; 12(9):581-2. PubMed ID: 9294792
    [No Abstract]   [Full Text] [Related]  

  • 20. A survey of the dose of ACE inhibitors prescribed by general physicians for patients with heart failure.
    McMullan R; Silke B
    Postgrad Med J; 2001 Dec; 77(914):765-8. PubMed ID: 11723314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.